HR 6238: NIH IMPROVE Act

HR 6238 in plain English: This bill gives the National Institutes of Health (NIH) formal legal authority to fund research aimed at improving health outcomes for pregnant and postpartum women, with a focus on populations that experience disproportionately worse outcomes. It authorizes $63.4 million per year from 2026 through 2030 for this purpose.

Stated purpose

To give the National Institutes of Health formal legal authority to run the IMPROVE Initiative, which funds research aimed at reducing maternal deaths and serious pregnancy complications, with a focus on populations that experience these problems at higher rates than the national average.

Key points

• Authorizes $63.4 million per year from 2026 to 2030 for NIH maternal and pregnancy health research
• Gives NIH formal statutory authority to award grants for improving outcomes for pregnant and postpartum women
• Directs focus toward populations disproportionately affected by poor maternal health outcomes

Arguments supporters make

• The U.S. has one of the highest maternal mortality rates among wealthy nations, and targeted federal research funding could help find and fix the causes.
• Focusing on communities with disproportionately high rates of maternal death and complications addresses a well-documented health equity gap.
• Giving NIH a clear legal mandate ensures the program cannot be quietly dropped and creates accountability for results.

Arguments opponents make

• Authorizing $63.4 million per year adds to federal spending at a time when many argue the government should reduce its budget footprint.
• Critics may argue that existing NIH programs already cover maternal health research, making a separate statutory initiative duplicative and unnecessary.
• Some may question whether federally directed research priorities are the most efficient approach, arguing that flexible funding without mandated focus areas produces better science.

Tradeoffs

Dedicating a specific funding stream to maternal health research means those dollars are directed toward this one area rather than being available for other health research priorities; the focused approach may accelerate progress on maternal outcomes but reduces flexibility in how NIH allocates its overall research budget.

Current status in Congress: Passed House.

NewsClear — neutral news & congressional tracking · Bill of the Week